EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the Wnt/β-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges

Ruixin Shi, Zhenwen Cao, Jie Li, Ru Ji, Zhijuan Guo

Frontiers in Oncology · 29.08.2025 · 15

DOI: 10.3389/fonc.2025.1633699 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 29.08.2025. Verfasst von Ruixin Shi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Medical University, Hohhot, China. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) remains the foremost contributor to global cancer mortality, largely attributable to metastatic dissemination and therapeutic refractoriness. Emerging data implicate the Wnt/β-catenin signaling cascade as a pivotal regulator of epithelial-mesenchymal plasticity, stemness acquisition, and multidrug tolerance in GC. This review delineates the molecular landscape of Wnt/β-catenin aberrations, encompassing genomic perturbations ( NAT10 , SMC4 ), non-coding RNA circuitry ( LINC00665 , circ0000670 ), and (epigenetic reprogramming (e.g., miR-33b hypermethylation). Mechanistically, these alterations cooperate with EMT drivers to potentiate metastatic outgrowth and therapeutic evasion. Of particular translational significance are emerging interventions targeting this axis: phytochemicals (Rutin, ginsenoside Rg3) with dual Wnt-CSC inhibitory activity, CRISPR-edited epigenetic modulators ( TET1 /FOXO4), and immune checkpoint blockade-Wnt inhibitor synergism. Notwithstanding preclinical success, clinical implementation faces two critical bottlenecks—pathway pleiotropy and biomarker paucity. To bridge this gap, we propose a precision oncology framework leveraging multi-omics-guided patient stratification, potentially reshaping GC therapeutic paradigms.

Schlagwörter

Stichwörter der Autor:innen

Wnt/β-catenin signaling pathwaychemoresistanceepithelial-mesenchymal transitiongastric cancertargeted therapy

Autor:innen und Institutionen

  • Inner Mongolia Medical University, Hohhot, China.
  • Inner Mongolia Medical University Affiliated Cancer Hospital, Hohhot, China.

Zitieren

APA

Shi, R., Cao, Z., Li, J., Ji, R., & Guo, Z. (2025). Targeting the Wnt/β-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1633699

Vancouver

Shi R, Cao Z, Li J, Ji R, Guo Z. Targeting the Wnt/β-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1633699

BibTeX
@article{Shi2025,
  author = {Shi, Ruixin and Cao, Zhenwen and Li, Jie and Ji, Ru and Guo, Zhijuan},
  title = {Targeting the Wnt/β-catenin pathway and epithelial-mesenchymal transition in gastric cancer: mechanisms, therapeutic strategies, and clinical challenges},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1633699}
}
Kostenlos starten →